UPDATE 4-Novartis CEO feels heat on U.S. generics, Cosentyx drop By: Reuters: Company News April 19, 2018 at 08:05 AM EDT * Cosentyx sales drop since Q4 worries analysts (Adds comments from CEO, updates shares) Read More >> Related Stocks: Amgen Gsk Plc ADR Novan Inc